Nefazodone Hydrochloride (AvKARE, Inc.)


Welcome to the PulseAid listing for the Nefazodone Hydrochloride drug offered from AvKARE, Inc.. This Serotonin Reuptake Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AvKARE, Inc.
NON-PROPRIETARY NAME: Nefazodone Hydrochloride
SUBSTANCE NAME: NEFAZODONE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin Reuptake Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-07-30
END MARKETING DATE: 0000-00-00


Nefazodone Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNefazodone Hydrochloride from AvKARE, Inc.
LABELER NAME: AvKARE, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2013-07-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42291-627_9e0e0d0e-1839-88ba-a57b-78fc5a7938b2
PRODUCT NDC: 42291-627
APPLICATION NUMBER: ANDA076037

Other NEFAZODONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AvKARE, Inc.Nefazodone Hydrochloride
Bryant Ranch PrepackNefazodone Hydrochloride
Rebel Distributors CorpNefazodone Hydrochloride
STAT RX USA LLCNEFAZODONE HYDROCHLORIDE
Teva Pharmaceuticals USA IncNefazodone Hydrochloride